Found 82 matching trials
NEPC Study: An Exploratory Safety and Efficacy Study With PSMA, SSTR2 and GRPR Targeted Radioligand Therapy in Metastatic Neuroendocrine Prostate Cancer. PHASE1 The purpose of this study is to evaluate the change in the expression of tr...
Show More Status
Active Not Recruiting
Location
Nebraska Cancer Specialists
Learn More & Join Trial
68Ga-DOTATATE Neuroblastoma Imaging Pilot PHASE2 Neuroblastoma is the most frequent extracranial childhood tumor, with an an...
Show More Location
McGill University Health Center - Children's hospital
Learn More & Join Trial
SUV on 68Ga-DOTATATE PET/CT and Ki-67 Index in Neuro-Endocrine Tumors PHASE3 Positron emission tomography/computed tomography (PET/CT) is an advanced nu...
Show More Location
Jewish General Hospital
Learn More & Join Trial
Al18F-NOTA-LM3 PET/CT in Patients With Pheochromocytoma and Paraganglioma NA The aim of this study is to evaluate the diagnostic performance of Al18F-NO...
Show More Location
Peking Union Medical College Hospital
Learn More & Join Trial
68Ga-DOTATATE PET for Management of Neuroendocrine Tumors NA This is a research study to collect information regarding usefulness of pos...
Show More Location
Princess Margaret Cancer Centre
Learn More & Join Trial
An Investigational Scan (68Ga-DOTATATE PET/CT) in Diagnosing Pediatric Metastatic Neuroendocrine Tumors EARLY_PHASE1 This trial studies how well an investigational scan called 68Ga-DOTATATE PE...
Show More Status
Active Not Recruiting
Location
Mayo Clinic in Rochester
Learn More & Join Trial
Dynamic Whole Body Positron Emission Tomography/Computed Tomography Imaging N/A Quantitative parameters obtained with dynamic whole body imaging using posi...
Show More Learn More & Join Trial
Molecular Imaging in Fabry Disease of the Heart N/A Better methods for early detection of cardiac involvement in Fabry disease ...
Show More Location
Cambridge University Hospital NHS Foundation Trust
Learn More & Join Trial
Natural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine Tumors PHASE2 Background:
People with von Hippel-Lindau (VHL) can have problems with a v...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
Dosimetry-Guided, Peptide Receptor Radiotherapy (PRRT) With 90Y-DOTA- tyr3-Octreotide (90Y-DOTATOC) PHASE2 This is a Phase 2 peptide receptor radionuclide therapy trial of 90Y-DOTATO...
Show More Location
University of Iowa Hospitals and Clinics
Learn More & Join Trial